A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the efficacy of ALKS 5461 when administered daily for 4 weeks to
adults with Major Depressive Disorder (MDD) and inadequate response to antidepressant
therapy.